114 related articles for article (PubMed ID: 18670123)
1. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
[TBL] [Abstract][Full Text] [Related]
2. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode.
Yoshikawa Y; Ueda E; Suzuki Y; Yanagihara N; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2001 May; 49(5):652-4. PubMed ID: 11383627
[TBL] [Abstract][Full Text] [Related]
3. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
4. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
6. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
7. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities.
Adachi Y; Yoshikawa Y; Sakurai H
Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552
[TBL] [Abstract][Full Text] [Related]
9. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
10. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
11. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
Moniz T; Amorim MJ; Ferreira R; Nunes A; Silva A; Queirós C; Leite A; Gameiro P; Sarmento B; Remião F; Yoshikawa Y; Sakurai H; Rangel M
J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
[TBL] [Abstract][Full Text] [Related]
13. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.
Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
16. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
[TBL] [Abstract][Full Text] [Related]
17. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
[TBL] [Abstract][Full Text] [Related]
18. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
Basuki W; Hiromura M; Sakurai H
J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
Rangel M; Tamura A; Fukushima C; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
[TBL] [Abstract][Full Text] [Related]
20. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
